Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 9184625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisapride

  2012cited by this paper
• Non-competitive inhibition of clomipramineN-demethylation by fluvoxamine

  2005cited by this paper
• A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

  2004cited by this paper
• Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.

  1996cited by this paper
• Elevated clozapine levels after fluvoxamine initiation.

  1996cited by this paper
• Combined pharmacotherapy for TS and OCD.

  1996cited by this paper
• Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

  1996cited by this paper
• Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines.

  1996cited by this paper
• The characterization and treatment of trichotillomania.

  1996cited by this paper
• Compulsive buying: a review.

  1996cited by this paper
• Newer antidepressants and the cytochrome P450 system.

  1996cited by this paper
• Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.

  1996cited by this paper
• Diagnosis, neurobiology, and treatment of pathological gambling.

  1996cited by this paper
• Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).

  1996cited by this paper
• Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.

  1996cited by this paper
• Fluoxetine withdrawal?

  1995cited by this paper
• Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

  1995cited by this paper
• Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

  1995cited by this paper
• Physical symptoms associated with paroxetine withdrawal.

  1995cited by this paper
• Clinical Relevance of Drug Interactions with Lithium

  1995cited by this paper
• Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.

  1995cited by this paper
• Adverse Events After the Abrupt Discontinuation of Paroxetine

  1995cited by this paper
• Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.

  1995cited by this paper
• A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder.

  1995cited by this paper
• Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa.

  1995cited by this paper
• A Seizure, and Electroencephalographic Signs of a Lowered Seizure Threshold, Associated with Fluvoxamine Treatment of Obsessive-Compulsive Disorder

  1995cited by this paper
• Paroxetine withdrawal syndrome.

  1995cited by this paper
• A possible paroxetine withdrawal syndrome.

  1995cited by this paper
• Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder.

  1995cited by this paper
• Compulsive sexual behaviors.

  1995cited by this paper
• A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania.

  1995cited by this paper
• Discontinuation reactions following sertraline.

  1995cited by this paper
• The effective treatment of severe repetitive behaviour with fluvoxamine in a 20 year old autistic female.

  1995cited by this paper
• Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.

  1995cited by this paper
• Severe psychiatric symptoms associated with paroxetine withdrawal.

  1995cited by this paper
• Comparative safety and tolerability of selective serotonin reuptake inhibitors

  1995cited by this paper
• Kleptomania, compulsive buying, and binge-eating disorder.

  1995cited by this paper
• A family study of obsessive-compulsive disorder.

  1995cited by this paper
• Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.

  1995cited by this paper
• Withdrawal reaction after sertraline discontinuation.

  1994cited by this paper
• Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

  1994cited by this paper
• Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.

  1994cited by this paper
• Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

  1994cited by this paper
• Obsessive compulsive spectrum disorders.

  1994cited by this paper
• A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.

  1994cited by this paper
• Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors.

  1994cited by this paper
• Trazodone for antidepressant-associated insomnia.

  1994cited by this paper
• Emergence of Symptoms of Tourette's Syndrome during Fluvoxamine Treatment of Obsessive–Compulsive Disorder

  1994cited by this paper
• Obsessive–Compulsive Disorder with and without a Chronic Tic Disorder

  1994cited by this paper
• Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.

  1994cited by this paper
• Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.

  1994cited by this paper
• The electrocardiographic effects of cetirizine in normal subjects

  1994cited by this paper
• Compulsive buying: a report of 20 cases.

  1994cited by this paper
• Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.

  1994cited by this paper
• Predictors of Treatment Response in Obsessive‐Compulsive Disorder: Multivariate Analyses From a Multicenter Trial of Clomipramine

  1994cited by this paper
• Self-injurious behavior and serotonin in Prader-Willi syndrome.

  1994cited by this paper
• Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

  1994cited by this paper
• Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.

  1994cited by this paper
• Successful Treatment of Fluvoxamine-Induced Anorgasmia by Cyproheptadine

  1994cited by this paper
• Open trial of fluvoxamine in the treatment of bulimia nervosa.

  1994cited by this paper
• Fluoxetine withdrawal and thalamic pain

  1994cited by this paper
• Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.

  1994cited by this paper
• Fluvoxamine treatment of body dysmorphic disorder.

  1994cited by this paper
• Physical symptoms associated with paroxetine discontinuation.

  1994cited by this paper
• Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.

  1993cited by this paper
• Fluoxetine for hypochondriacal patients without major depression.

  1993cited by this paper
• The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.

  1993cited by this paper
• A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

  1993cited by this paper
• The abrupt discontinuation of fluvoxamine in patients with panic disorder.

  1993cited by this paper
• Is there a serotonergic withdrawal syndrome?

  1993cited by this paper
• Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing.

  1993cited by this paper
• Serotonin syndrome induced by fluvoxamine-lithium interaction.

  1993cited by this paper
• Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.

  1993cited by this paper
• Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

  1993cited by this paper
• Acute Fluvoxamine Poisoning

  1993cited by this paper
• Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly Subjects

  1992cited by this paper
• Treatment of pathological gambling with clomipramine.

  1992cited by this paper
• Treatment of fluoxetine-induced anorgasmia with amantadine.

  1992cited by this paper
• A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

  1992cited by this paper
• A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.

  1992cited by this paper
• Paraphilias: A double-blind crossover comparison of clomipramine versus desipramine

  1992cited by this paper
• Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.

  1992cited by this paper
• An integrated approach to treatment of obsessive compulsive disorder.

  1992cited by this paper
• Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.

  1992cited by this paper
• Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers

  1992cited by this paper
• Fluvoxamine withdrawal syndrome

  1992cited by this paper
• Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.

  1992cited by this paper
• Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.

  1992cited by this paper
• Interaction Between Fluvoxamine and Imipramine/Desipramine in Four Patients

  1992cited by this paper
• Hypochondriasis and obsessive compulsive disorder.

  1992cited by this paper
• Fenfluramine Augmentation of Clomipramine Treatment of Obsessive Compulsive Disorder

  1991cited by this paper
• Characteristics of 60 adult chronic hair pullers.

  1991cited by this paper
• 5-HT3 Receptor Antagonists

  1991cited by this paper
• Regional cerebral glucose metabolism of women with trichotillomania.

  1991cited by this paper
• Extrapyramidal symptoms upon discontinuation of fluoxetine.

  1991cited by this paper
• The serotonin syndrome.

  1991cited by this paper
• A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine‐Treated Patients with Obsessive‐Compulsive Disorder

  1991cited by this paper
• Case report of successful treatment of bulimia nervosa with fluvoxamine.

  1991cited by this paper
• A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.

  1991cited by this paper
• The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.

  1991cited by this paper

• Fluoxetine substitution for deprescribing antidepressants: a technical approach

  2025cites this paper
• Fluvoxamine maleate alleviates amyloid-beta load and neuroinflammation in 5XFAD mice to ameliorate Alzheimer disease pathology

  2024cites this paper
• Evidence of pharmacogenetics-based fluvoxamine use as an add-on to clozapine treatment in psychiatry.

  2022cites this paper
• Pathological Gambling In A Patient With Parkinson’s Disease And Valproate Response

  2019cites this paper
• Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive–compulsive disorder

  2017cites this paper
• Corrosion inhibition characteristics of 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine on steel in simulated oilfield acidizing solution

  2017cites this paper
• Fluvoxamine-based corrosion inhibitors for J55 steel in aggressive oil and gas well treatment fluids

  2017cites this paper
• Determining face, predictive, construct validity and novel receptor targets in a spontaneous compulsive-like mouse model

  2017cites this paper
• Origins of Obsessive‐Compulsive Disorder: Developmental and Evolutionary Perspectives

  2015cites this paper
• Pathophysiology of Obsessive–Compulsive Disorder: Affected Brain Regions and Challenge Towards Discovery of Novel Drug Treatment

  2014cites this paper
• TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER ( OCD ) : CURRENT KNOWLEDGE AND OPEN QUESTIONS

  2013cites this paper
• Approaches to Treatment Resistance

  2012cites this paper
• Clinical impact of fluvoxamine-mediated long QTU syndrome

  2011cites this paper
• Different Views of Anxiety Disorders

  2011cites this paper
• Comparison of Metacognitive Therapy, Fluvoxamine and Combined treatment in Improving Metacognitive Beliefs and Subjective Distress of Patients with Obsessive-Compulsive Disorder

  2011cites this paper
• The Treatment of Obsessive-Compulsive Disorder and the Approaches to Treatment Resistance

  2011cites this paper
• Aggression, Gewalt, Amok, Stalking

  2011cites this paper
• Argumentación del tratamiento psicofarmacológico y biológico en el trastorno obsesivo-compulsivo resistente y refractario.

  2011cites this paper
• Il trattamento del disturbo ossessivo-compulsivo resistente

  2011cites this paper
• The Significance of Affective Problems in Obsessive-Compulsive Disorder

  2010cites this paper
• D-Cycloserine Augmentation of Cognitive-Behavioral Therapy: Directions for Pilot Research in Pediatric Obsessive-Compulsive Disorder

  2010cites this paper
• Benzhexol-dependence resulting from self-medication for intermittent explosive disorder

  2009cites this paper
• Management of obsessive-compulsive disorder with fluvoxamine extended release

  2009cites this paper
• Practice guideline for the treatment of patients with obsessive-compulsive disorder.

  2007cites this paper
• Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.

  2007cites this paper
• More than Medication-Achieving Goals through Psychotherapy in Patients with Obsessive Compulsive Disorder.

  2007cites this paper
• Unmet need for services and interventions among adolescents with mental disorders.

  2007cites this paper
• PRACT ICE GUIDEL INE FOR THE Treatment of Patients With Obsessive-Compulsive Disorder WORK GROUP ON OBSESSIVE-COMPULSIVE DISORDER

  2007cites this paper
• Fluvoxamine as an adjunctive agent in schizophrenia.

  2006cites this paper
• Brain fMRI in clinical pharmacological studies

  2006cites this paper
• Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.

  2006cites this paper
• Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.

  2006cites this paper
• Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder?

  2006cites this paper
• Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

  2005cites this paper
• A Randomized Controlled Trial of Japanese Patients with Obsessive-Compulsive Disorder – Effectiveness of Behavior Therapy and Fluvoxamine

  2005cites this paper
• Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.

  2005cites this paper
• ‘Compulsive’ lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam

  2004cites this paper
• Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology.

  2004cites this paper
• Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder.

  2003cites this paper
• A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

  2003cites this paper
• A review of pharmacologic treatments for obsessive-compulsive disorder.

  2003cites this paper
• Venlafaxine in treatment-resistant obsessive-compulsive disorder.

  2003cites this paper
• Biological, Pharmacological, and Somatic Treatments for Obsessive-Compulsive Disorder

  2003cites this paper
• Obsessive–compulsive spectrum conditions in obsessive‐compulsive disorder and other anxiety disorders

  2003cites this paper
• Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder

  2002cites this paper
• Fluvoxamine: Safety Profile in Extensive Post-Marketing Surveillance

  2002cites this paper
• Serotonin-selektive Antidepressiva(SSRI, DSA)

  2002cites this paper
• Obsessive-compulsive disorder

  2002cites this paper
• Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.

  2001cites this paper
• Management of anxiety disorders: The added challenge of comorbidity

  2001influential citation
• A subtype of auditory verbal hallucinations responds to fluvoxamine.

  2001cites this paper
• Treatment of obsessive-compulsive disorder in children and adolescents.

  2000cites this paper
• [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].

  2000cites this paper
• Zwangsstörung, frontostriatales System und Beeinflussung des serotonergen Systems

  2000cites this paper
• The first Japanese pediatric case of obsessive–compulsive disorder who responded to a selective serotonin re‐uptake inhibitor

  2000cites this paper
• Serotonergic drugs in the treatment of depressive and anxiety disorders

  2000cites this paper
• Factors Affecting Prescribing of the Newer Antidepressants

  2000cites this paper
• Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy.

  1999cites this paper
• Anxiety disorders.

  1999cites this paper
• Obsessive-compulsive disorder: diagnosis and treatment.

  1999cites this paper
• Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic Disorders

  1999cites this paper
• Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene.

  1998cites this paper